Furthermore, we found that MAP4K4 levels in human liver biopsies were positively correlated with the key lesions of NAFLD/NASH (i.e., hepatic steatosis, inflammation, fibrosis, and hepatocellular ballooning). This evidence concerns the gene MAP4K4 and metabolic dysfunction-associated steatotic liver disease.